New Stent-Graft device under scrutiny for treating dangerous aortic aneurysms

NCT ID NCT07147569

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 100 people with thoracoabdominal or pararenal aortic aneurysms who receive the GORE EXCLUDER TAMBE device, a stent-graft system placed through blood vessels. Researchers will track how often the device is successfully implanted and works without leaks or serious complications over 12 months. The goal is to confirm the device's safety and effectiveness in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (a stent-graft device)
What this could lead to
If successful, this could confirm that the device is a safe, effective option for treating complex aortic aneurysms without open surgery.
What could go wrong
This is an observational post-market study, not a randomized trial. Results may not apply to all patients, and risks include serious complications like stroke, paralysis, or kidney failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARARENAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Morinomiya Hospital

    RECRUITING

    Osaka, Japan

  • Nagoya University Hospital

    RECRUITING

    Nagoya, Japan

  • Osaka International Medical & Science Center Osaka Police Hospital

    RECRUITING

    Osaka, Japan

  • The Jikei University Hospital

    RECRUITING

    Minatoku, Japan

  • The University of Osaka Hospital

    RECRUITING

    Suita, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.